Twist Bioscience (TWST) Research & Development (2017 - 2026)

Twist Bioscience has disclosed Research & Development across 10 years of filings, most recently posting $19.7 million for Q1 2026.

• In Q1 2026, Research & Development fell 17.65% year-over-year to $19.7 million; the TTM figure through Mar 2026 stood at $71.9 million (down 19.07% YoY), while the FY2025 annual figure was $80.3 million, down 11.63% from the prior year.
• Research & Development improved to $19.7 million in Q1 2026, from $17.1 million in the prior quarter.
• Over the last five years, Research & Development for TWST reached as high as $36.8 million in Q2 2022 and fell as low as $17.0 million in Q3 2025.
• The 5-year median for Research & Development is $23.7 million (2023), against an average of $24.3 million.
• Annual changes were most pronounced in 2022 — Research & Development soared 97.78% — and 2023, when it slumped 33.42%.
• A 5-year view of Research & Development shows it stood at $31.2 million in 2022, then retreated by 26.06% to $23.1 million in 2023, then retreated by 7.76% to $21.3 million in 2024, then slipped by 19.6% to $17.1 million in 2025, then gained by 14.97% to $19.7 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $19.7 million, $17.1 million, and $17.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.